NEW YORK (TheStreet) -- CHANGE IN RATINGS:
American International AIG rated new outperform at FBR. $44 price target. Company is attractively valued and will likely continue to deploy capital.
America Movil AMX upgraded to buy at TheStreet Ratings.
AOL AOL rated new hold at Cantor. $32 price target. Operating turnaround remains a work in progress.
Bel Fuse BELFB upgraded to buy at TheStreet Ratings.
Brookdale Senior Living BKD upgraded at BofA to buy from neutral, Bank of America Merrill Lynch said. $31 price target. Better fundamental outlook.
Cardtronics CATM upgraded at JP Morgan to overweight from neutral, JP Morgan said. $31 price target. Reverse interchange concerns overdone.
Cathay General CATY downgraded at DA Davidson from buy to neutral, DA Davidson said. Valuation call, as the stock is up 30% over the past year.
Cummins CMI downgraded at Jefferies to hold from buy, Jefferies said. Valuation call.
Community Health Systems CYH upgraded at BofA to buy from neutral, Bank of America Merrill Lynch said. $45 price target. Reform positives clear and story is de risked.
Forest Laboratories FRX upgraded at Goldman from sell to neutral, Goldman Sachs said. Company can improve its industry-low margins over time. $40 price target.
General Mills GIS downgraded at Goldman from neutral to sell, Goldman Sachs said. Company will likely lose market share in cereal and fall short of consensus expectations. $40 price target.
Hubbell HUBB upgraded at JP Morgan to overweight from neutral, JP Morgan said. $93 price target. Risk/reward now attractive.
Interpublic IPC downgraded at Morgan Stanley from overweight to equal-weight, Morgan Stanley said. $12 price target. Upside will likely be capped by a slower macro environment.
JC Penney JCP downgraded at UBS to sell from neutral, UBS said. $13 price target. SSS and gross margins are major earnings risks in 4Q.
3M MMM downgraded at JP Morgan from neutral to underweight, JP Morgan said. $97 price target. Company lacks near-term catalysts.
Meritage Homes MTH upgraded at JP Morgan from neutral to overweight, JP Morgan said. Company has lagged its peers and can deliver above-average order growth in 2013.
Maxim Integrated MXIM upgraded at JP Morgan from neutral to overweight, JP Morgan said. Company is leveraged to Samsung, which should continue to gain market share.
Oasis Petroleum OAS upgraded at Wells Fargo to outperform from market perform, Wells Fargo said. $40 to $45 valuation range. Strong operational momentum.
Principal Financial PFG downgraded at UBS to sell from neutral, UBS said. $27 price target. Accumulation business to remain under pressure.
Philip Morris PM upgraded at Goldman from neutral to buy, Goldman Sachs said. $103 price target. Company was also placed on the Conviction Buy list. Company offers growth and yield at an attractive valuation.
Pepco POM downgraded at Credit Suisse from outperform to neutral, Credit Suisse said. $20.50 price target. Company is facing multiple growth headwinds.
Perrigo PRGO downgraded at Goldman from neutral to sell, Goldman Sachs said. $110 price target. Growth could slow in the next few quarters.
Research in Motion RIMM downgraded at BMO to underperform, BMO Capital said. $9 price target. New BB10 phones will likely not stem market share losses.
JM Smucker SJM downgraded at Goldman from buy to neutral, Goldman Sachs said. Valuation call, based on a $93 price target.
SodaStream International SODA rated new buy at Citigroup. $60 price target. Skeptics abound but momentum is hard to dispute.
Standard Pacific SPF downgraded at JP Morgan from neutral to underweight, JP Morgan said. Valuation call, as the stock trades at a 35% premium to its peers.
Molson Coors TAP rated new buy at Nomura. $54 price target. Investor sentiment is too low and the company can continue to cut costs.
Tenet Healthcare THC upgraded at BofA/Merrill from neutral to buy, Bank of America/Merrill Lynch said. $44 price target. Company is improving margins and leveraging its balance sheet.
Targa Resources TRGP downgraded at BofA to neutral from buy, Bank of America Merrill Lynch said. $60 price target. Valuation call.
Watson Pharmaceuticals WPI downgraded at Goldman from buy to neutral, Goldman Sachs said. $96 price target. Valuation call, as the stock gained 43% in 2012.
Watsco WSO downgraded at JP Morgan to underweight, JP Morgan said. Valuation call, based on a $72 price target.
STOCK COMMENTS / EPS CHANGES
AGCO AGCO target raised at Jefferies to $58, Jefferies said. Long- term opportunity remains. Buy rating.
American Express AXP numbers increased at Credit Suisse. AXP estimates were raised through 2015, Credit Suisse said. Company is cutting costs. Underperform rating and new $59 price target.
Chipotle Mexican Grill CMG numbers raised at UBS. Shares of CMG now seen reaching $310, UBS said. Estimates also increased on expectations of a strong quarter. Neutral rating.
Campbell Soup CPB cut from Conviction Buy List at Goldman. Turnaround is progressing slower than expected. $40 price target.
Deckers DECK estimates, target cut at Piper. Shares of DECK now seen reaching $34, according to Piper Jaffray. Estimates also reduced, as the company is marking down prices in the UK. Neutral rating.
Hertz HTZ added to Priority Stock List at Wells. HTZ was added to the Priority Stock list, Wells Fargo said. Company is attractively valued and can deliver solid earnings growth over the next couple of years.
Nokia NOK estimates, target raised at BMO. Shares of NOK now seen reaching $3, according to BMO Capital. Estimates also increased, given the company's new guidance.
Praxair PX target raised at Jefferies to $120, Jefferies said. Strong bidding activity. Buy rating.
>To submit a news tip, email: firstname.lastname@example.org.
READERS ALSO LIKE: